Sponsored by:

headline-text-20005

Erik Ridley Headshot
Erik L. Ridley
Nov 24, 2000
Ge12 17 99 small
body-text-20005
Latest in Nuclear Medicine
A Ibrain
Telix doses first patient in glioblastoma trial
April 15, 2026
Molecular Imaging News Platform: trends, insights, professional views.
Sponsored
Molecular Imaging News Platform: trends, insights, professional views.
April 14, 2026
Atom Molecule
First patients treated in RYZ401 radiopharmaceutical trial
April 8, 2026
Isotopes1
Consortium launches 5-year plan to improve theranostics outcomes
April 6, 2026
Related Stories
Dementiasmall
Nuclear Medicine
FDG-PET clears up metabolic murkiness between dementia and Alzheimer's
Positracesmall
CT
SMV wins FDA clearance for Positrace hybrid PET/CT camera
Gammasmall07 19 00 rn
Nuclear Medicine
Gamma Medica sees better lymph node imaging with handheld probe
Molecular Imaging News Platform: trends, insights, professional views.
Sponsor Content
Molecular Imaging News Platform: trends, insights, professional views.
More in Nuclear Medicine
Telix doses first patient in glioblastoma trial
By AuntMinnie.com staff writers
The patient was dosed at Austin Health in Melbourne, Australia.
April 15, 2026
A Ibrain
Shine receives $263M conditional loan for Mo-99 isotope facility
By AuntMinnie.com staff writers
Shine has received a conditional loan from the U.S. DOE to complete the Chrysalis medical isotope production facility for Mo-99.
April 9, 2026
Chrysalis, Shine’s large-scale irradiation facility, will complement the existing supply chain with the goal of ensuring a sustainable and reliable source of isotopes, including Mo-99.
First patients treated in RYZ401 radiopharmaceutical trial
By AuntMinnie.com staff writers
RYZ401 is an investigational actinium-225 (AC-225)-based radiopharmaceutical targeting somatostatin receptors in neuroendocrine tumors.
April 8, 2026
Atom Molecule
Consortium launches 5-year plan to improve theranostics outcomes
By Will Morton
The project aims to pave the way for personalized radiopharmaceutical therapy.
April 6, 2026
Isotopes1
SpectronRx raises $85M to expand radiopharmaceutical production
By AuntMinnie.com staff writers
The funding will support infrastructure investment at the company's Grissom Aeroplex campus in Indiana.
April 2, 2026
Cash
Cardinal Health expands Ac-225 production
By AuntMinnie.com staff writers
Since launching routine Ac-225 production at scale in late 2024, the company said it has quadrupled its weekly output.
April 1, 2026
Isotopes1
Radiopharmaceutical Therapy Tracker
With so many targeted diagnostic and therapeutic radiopharmaceuticals in development for cancer care, AuntMinnie's new pipeline update tool can help keep track.
March 30, 2026
Rt Tracker
Varian nets FDA clearance for TrueBeam in osteoarthritis treatment
By AuntMinnie.com staff writers
Varian has received U.S. FDA clearance for the use of low-dose radiation therapy with its Varian TrueBeam radiotherapy systems.
March 19, 2026
TrueBeam radiotherapy system
TerraPower Isotopes to build Ac-225 facility in Philadelphia
By AuntMinnie.com staff writers
The new site will increase the company's actinium-225 (Ac-225) production capacity 20-fold.
March 18, 2026
Isotopes1
JAMA study shows wide global variation in cardiac imaging radiation dose
By Kate Madden Yee
"Radiation doses varied significantly between imaging tests and among patients receiving the same tests," researchers reported.
February 25, 2026
Radiation Symbols Adobe Mia
Genetic mutations linked to poor outcomes in Pluvicto patients
By Will Morton
TP53, PTEN, and RB1 mutations may serve as prognostic biomarkers.
February 23, 2026
Dna Blue
The rise of theranostics: Part 7 -- Nuclear medicine technologists' rapid evolution
By Liz Carey
As theranostics gains speed, nuclear medicine technologists (NMTs) face a defining moment.
February 19, 2026
Image 3 Simulation Lab Courtesy Of Uab Feb 2026
Page 1 of 441
Next Page